Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Amanda K. L. Anderson"'
PDF file, 83K, Supplementary Figure 1. Longitudinal association of QOL and telomere MFI index of CD14+ and CD14- subsets.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ff8bf96f640ffc6720c514d318d18dd
https://doi.org/10.1158/1940-6207.22525097.v1
https://doi.org/10.1158/1940-6207.22525097.v1
Shortened telomere length is associated with increased cancer incidence and mortality. Populations experiencing chronic stress have accelerated telomere shortening. In this exploratory study, we examined associations between longitudinal changes in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b644ad3917b7e33eb964245d8657f4bb
https://doi.org/10.1158/1940-6207.c.6544568
https://doi.org/10.1158/1940-6207.c.6544568
Autor:
Rene Costello, William L. Dahut, Heather J. Chalfin, Seth M. Steinberg, David I. Quinn, Marissa Mallek, Jane B. Trepel, Ryan Dittamore, John Wright, Yipeng Wang, Robin Richardson, Adam Jendrisak, Jacqueline Cadena, James L. Gulley, Carlos Diaz, Tiziano Pramparo, Yen Lin Chu, Sumanta K. Pal, Rachel Krupa, Primo N. Lara, Olena Sierra Ortiz, Andrea B. Apolo, Howard Streicher, Amanda K. L. Anderson, Lisa M. Cordes, Donald P. Bottaro, Lisa Ley, Amir Mortazavi, Joseph D. Schonhoft, Mark N. Stein, Scot Anthony Niglio
Publikováno v:
Clinical Cancer Research. 27:1391-1398
Purpose: Circulating tumor cells (CTC) are under investigation as a minimally invasive liquid biopsy that may improve risk stratification and treatment selection. CTCs uniquely allow for digital pathology of individual malignant cell morphology and m
Autor:
Nicole A. Schreiber, Ryan Dittamore, Lori E. Lowes, Eric Winquist, Alison L. Allan, Glenn Heller, Brigit McLaughlin, Gerhardt Attard, Yipeng Wang, Anuradha Jayaram, Amanda K. L. Anderson, Martin Fleisher, Sarah Orr, Ryon P. Graf, David S.K. Lu, Howard I. Scher
Publikováno v:
Anatomy and Cell Biology Publications
IMPORTANCE A blood test to determine whether to treat patients with metastatic castration-resistant prostate cancer (mCRPC) with an androgen receptor signaling (ARS) inhibitor or taxane is an unmet medical need. OBJECTIVE To determine whether a valid
Autor:
Rene Costello, Amir Mortazavi, Joseph D. Schonhoft, Andrea B. Apolo, Lincy Chu, Primo N. Lara, Lisa M. Cordes, Sumanta K. Pal, Ryan Dittamore, Donald P. Bottaro, Christian Mayfield, Zishuo Ian Hu, Jane B. Trepel, Marissa Mallek, Carlos Diaz, Yipeng Wang, Mark N. Stein, Seth M. Steinberg, Amanda K. L. Anderson
Publikováno v:
Journal of Clinical Oncology. 37:4555-4555
4555 Background: CTCs may serve as biomarkers for clinical outcomes in GU tumor pts. We examined the association between baseline CTC enumeration, CTC heterogeneity, CTC morphologic subtypes, and progression-free-survival, overall survival and respon
Autor:
Nicole A. Schreiber, Brigit McLaughlin, Ryan Dittamore, Howard I. Scher, Eric Winquist, Sarah Orr, Alison L. Allan, Ryon P. Graf, David S.K. Lu, Lori E. Lowes, Yipeng Wang, Gerhardt Attard, Glenn Heller, Amanda K. L. Anderson, Martin Fleisher
Publikováno v:
Journal of Clinical Oncology. 36:273-273
273 Background: A previous analysis of 161 patients (pts) tested for nuclear-localized AR-V7(+) CTCs showed a therapy interaction between AR-V7 positivity and improved overall survival (OS) on taxane chemotherapy vs. androgen receptor signaling inhib
Autor:
Jakob Dupont, Chun Zhang, Eric Holmgren, Lei Zhou, Gretchen M. Argast, Adam Jendrisak, Sarah Orr, Charles M. Rudin, David R. Spigel, Ryon P. Graf, Anne C. Chiang, Leonardo Faoro, Ann M. Kapoun, John Lewicki, Amanda K. L. Anderson, Priscilla Ontiveros
Publikováno v:
Cancer Research. 77:1727-1727
Background: The NOTCH pathway has been identified as a key therapeutic pathway in SCLC. Tarextumab (TRXT, anti-Notch2/3, OMP-59R5) is a fully human monoclonal antibody that targets the Notch2 and Notch3 receptors. PINNACLE is a Phase 1b/2 trial of TR
Autor:
Premal Patel, Jane Petersen, Dena Marrinucci, Ling Huw, Shidong Jia, Shannon L. Werner, Amanda K. L. Anderson, Sarah Baird
Publikováno v:
Journal of Clinical Oncology. 34:195-195
195 Background: Detection and characterization of CTCs offers a minimally invasive mechanism for understanding patient response to therapy and disease evolution. Here we describe a proprietary technology platform to examine CTC incidence, N-terminal
Autor:
Dena Marrinucci, Florence Y. Lee, Amanda K. L. Anderson, Angela Yu, Vincent A. DiPippo, Wells W. Magargal, William C. Olson
Publikováno v:
Journal of Clinical Oncology. 32:266-266
266 Background: Prostate-specific membrane antigen (PSMA) is expressed ubiquitously in prostate adenocarcinoma, and the intensity of expression increases with disease aggressiveness. Exploiting PSMA for therapy could potentially be aided by a minimal